Medical Pharmaceuticals The most-up-to-date pharmaceutical news stories, including medical, cosmetic, and supplemental treatments. This section contains releases covering all aspects of the pharmaceutical sector, from research, development, and testing, through to product launches and marketing. Topics include clinical trials and studies, as well as updates on the FDA approval process for new treatment options. Learn about upcoming events, conferences, and educational initiatives. Also included is financial and corporate information from the sector, such as board decisions, appointments and changes, industry awards, and quarterly reports.

Latest

08:00 ET Mayfair First Breast Imaging Practice in Alberta to Adopt Volpara® Enterprise™ Software

Mayfair is the first medical imaging practice in Alberta to offer Volpara®Enterprise™ software, which helps breast imaging providers deliver high...


08:00 ET Teligent, Inc. To Present At Oppenheimer 27th Annual Healthcare Conference On March 22, 2017

Teligent, Inc. (NASDAQ: TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at the Oppenheimer 27th Annual...


08:00 ET ClarVista Medical Completes Important Milestone to Advance Novel Modular Intraocular Lens for Cataract Lens Replacement

ClarVista Medical, Inc. ("ClarVista"), a privately-held ophthalmic device company developing the HARMONI Modular IOL System, a novel intraocular...


08:00 ET Imprimis Pharmaceuticals to Raise $3.1 Million in Registered Direct Offering

Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), an ophthalmology-focused pharmaceutical company, announced today that it has entered into agreements...


08:00 ET AMRI Receives CMO Leadership Awards for Excellence

AMRI (NASDAQ: AMRI), a global contract research, development and manufacturing organization that has been working with the life sciences...


07:50 ET Medical Laboratories Stocks Under Scanner -- Organovo, DexCom, Quest Diagnostics, and Alere

On Tuesday, March 21, 2017, the NASDAQ Composite ended the trading session at 5,793.83, down 1.82%; the Dow Jones Industrial Average edged 1.14%...


07:35 ET ISCDD Celebrates 15th Anniversary of Improving CNS Drug Development Through Collaboration Amongst Stakeholders

The International Society for CNS Drug Development (ISCDD) is celebrating its 15th anniversary at the ISCDD 2017 Annual Meeting, March 22nd—24th,...


07:31 ET Allergan Announces Availability of RESTASIS MULTIDOSE™ (Cyclosporine Ophthalmic Emulsion) 0.05% -- the First FDA-Approved Preservative Free Prescription Eye Drop Available in a Multidose Bottle

Allergan plc (NYSE: AGN) today announced the availability of RESTASIS MULTIDOSE™, which is the same preservative-free RESTASIS® formulation, but...


07:30 ET Sanofi Genzyme Extends its Multiple Myeloma Journey Partners Program to Cities Nationwide to Help Improve Patient Outcomes through Peer-to-Peer Education

Sanofi Genzyme, the specialty care global business unit of Sanofi, today announced the extension of the Multiple Myeloma Journey Partners Program...


07:30 ET Invitae announces expansion of its genetic testing offering to include unique test for Spinal Muscular Atrophy (SMA) during the 2017 ACMG Annual Clinical Genetics Meeting

Invitae Corporation (NYSE: NVTA), one of the fastest growing genetic information companies, today announced the availability of a new genetic test...


07:15 ET Healthcare Stocks on Investors' Radar -- Depomed, Novartis AG, TherapeuticsMD, and Tonix Pharma

This morning, Stock-Callers.com features four equities in the Healthcare sector, and they are: Depomed Inc. (NASDAQ: DEPO), Novartis AG (NYSE:...


07:15 ET Dr. Carl H. June, Cancer Immunotherapy Pioneer, Joins CytoSorbents Scientific Advisory Board

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood filter to treat deadly...


07:05 ET Tumor Ablation Market to Reach US$1.9 Billion by 2024: Rising Prevalence of Cancer to Produce Lucrative Opportunity for Growth

According to a research report by Transparency Market Research (TMR), the global tumor ablation market is fragmented and highly competitive in...


07:02 ET RXi Pharmaceuticals to Present at the 5th Annual Cancer BioPartnering & Investment Forum

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet...


07:00 ET Personal Genome Diagnostics Announces Expanded Cancer Testing Contract with U.S. Department of Veteran Affairs

Personal Genome Diagnostics Inc. (PGDx) today announced an expansion of its cancer testing contract with the U.S. Department of Veterans Affairs...


07:00 ET Compugen to Present CGEN-15001 Autoimmune Product Candidate at Upcoming Conferences

Compugen Ltd. (NASDAQ: CGEN), a therapeutic discovery company, announced today that abstracts highlighting CGEN-15001, the Company's autoimmune...


07:00 ET Intec Pharma Initiates Phase I Trial of Accordion Pill for Cannabinoid Therapies

Expects Phase I Results in the Third Quarter of 2017 Intec Pharma Ltd. (Nasdaq; TASE: NTEC), a clinical stage biopharmaceutical company focused...


07:00 ET Shire Receives FDA Fast Track Designation for Recombinant ADAMTS13 (SHP655) for Treatment of Hereditary Thrombotic Thrombocytopenic Purpura

Shire plc (LSE: SHP, NASDAQ: SHPG) today announced that the United States Food and Drug Administration (FDA) has granted Fast Track designation...


06:30 ET Cannabis Testing Market Worth 1,416.3 Million USD by 2021

According to a new market research report "Cannabis Testing Market by Product & Software (LC, GC, Spectroscopy (MS, Atomic), Column,...


06:30 ET InfuSystem Holdings, Inc. Reports Fourth Quarter And Year End 2016 Financial Results

InfuSystem Holdings, Inc. (NYSE MKT: INFU), a leading national provider of infusion pumps and related services for the healthcare industry in the...